Tag: Merit Medical
Merit Medical announces FDA approval of the Wrapsody cell-impermeable endoprosthesis
Merit Medical Systems announced today that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the US Food and Drug Administration (FDA). With this...
WAVE trial AVG cohort also benefits at six months with Wrapsody
Newly released six-month results from single-arm arteriovenous graft (AVG) cohort in the WAVE (Wrapsody arteriovenous access efficacy) trial showed target lesion and access circuit...
Wrapsody WAVE trial demonstrates superior patency versus standard of care in...
Merit Medical has today announced positive six-month findings from the randomized arteriovenous (AV) fistula arm of its Wrapsody arteriovenous access efficacy (WAVE) pivotal trial....
First patient enrolled in Wrapsody endoprosthesis registry study
Merit Medical has announced the successful enrollment of the first patient in its WRAP registry study in a press release. The study will evaluate...